ADC Therapeutics Cash Flow Statement (2023-2026) | ADCT

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -48.15M-45.31M-46.00M-35.95M-43.71M-38.60M-56.65M-40.97M-32.97M
Depreciation and Depletion (Quarter) 0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Share-based Compensation (Quarter) 8.07M1.12M2.08M2.22M0.16M1.99M2.81M1.62M2.42M1.81M2.00M0.67M2.44M
Deferred Taxes (Quarter) -0.07M-5.10M-0.58M42.85M
Gains from Investment Securities (Quarter) -0.02M-0.14M0.28M0.28M2.20M-1.13M0.67M-0.40M-0.43M0.47M-2.23M
Asset Writedowns and Impairment (Quarter) 0.05M0.73M0.83M0.75M0.29M0.48M1.25M0.39M0.24M0.41M1.47M
Cash from Operations (Quarter) -15.39M-34.99M-36.67M-31.63M-44.09M-32.84M-25.04M-21.85M-56.33M-24.09M-29.63M-31.12M-29.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.86M0.14M11.05M7.16M6.86M-5.84M0.47M26.73M7.07M6.88M-12.89M0.11M6.84M
Amortization of Deferred Charges (Quarter) 0.83M0.67M0.82M0.69M0.50M0.44M0.52M-0.56M0.19M0.65M0.73M0.25M0.23M
Depreciation & Amortization (CF) (Quarter) 0.26M0.27M0.32M0.34M0.33M0.33M0.34M0.34M0.34M0.36M
Change in Working Capital
Change in Receivables (Quarter) -48.90M-0.19M-2.70M4.00M-2.00M-0.32M1.26M-3.71M11.45M-5.58M-3.27M6.19M1.93M
Change in Inventory (Quarter) 0.35M2.05M3.48M-0.17M0.57M-0.52M0.88M2.80M0.31M0.71M0.52M0.85M-0.02M
Change in Account Payables (Quarter) -3.66M2.98M-2.71M6.57M-1.25M-4.84M4.87M3.68M-2.46M-6.22M-1.29M0.93M-3.87M
Change in Accured Expenses (Quarter) -12.30M-3.29M-0.52M1.96M-3.54M-2.19M5.57M11.30M-20.63M12.04M-0.80M1.97M-3.18M
Change in Taxes (Quarter) 0.06M
Other Working Capital Changes (Quarter) 3.10M-4.35M8.64M-5.34M6.20M-2.36M2.98M-3.86M7.94M-9.53M0.21M-0.25M
Investing Activities
Capital Expenditures (Quarter) 0.41M-0.14M2.62M-2.82M0.53M0.03M-0.52M0.83M0.26M-0.26M0.26M0.03M
Cash from Investing Activities (Quarter) -1.02M-1.21M-0.66M-0.33M-0.53M-0.03M-0.22M-0.09M-0.26M0.66M-0.03M
Financing Activities
Cash from Financing Activities (Quarter) 0.42M73.10M0.35M-0.00M0.36M98.70M-0.88M-1.12M0.27M93.78M-0.20M57.09M-0.58M
Additional items
Exchange Rate Effect (Quarter) 0.09M0.06M-0.12M0.15M-0.04M0.01M0.29M-0.34M0.16M0.16M0.01M-0.03M-0.01M
Change in Cash (Quarter) -15.98M36.90M-36.98M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.62M-30.32M
Free Cash Flow (Quarter) -15.80M-34.85M-39.29M-28.81M-44.63M-32.88M-24.52M-22.68M-56.60M-24.09M-29.37M-31.39M-29.74M
Net Cash Flow (Quarter) -15.98M36.90M-36.98M-31.96M-44.27M65.82M-26.14M-23.06M-56.33M69.70M-29.83M26.62M-30.32M